Page last updated: 2024-11-06

3,3',5-triiodothyroacetic acid and Leukemia, Myeloid

3,3',5-triiodothyroacetic acid has been researched along with Leukemia, Myeloid in 1 studies

tiratricol : A monocarboxylic acid that is (4-hydroxy-3,5-diiodophenyl)acetic acid in which the phenolic hydroxy group has been replaced by a 4-hydroxy-3-iodophenoxy group. It is a thyroid hormone analogue that has been used in the treatment of thyroid hormone resistance syndrome.

Leukemia, Myeloid: Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
ALEXANDER, WD1
BISSET, SK1

Other Studies

1 other study available for 3,3',5-triiodothyroacetic acid and Leukemia, Myeloid

ArticleYear
Immediate effect of triiodothyroacetic acid on oxygen consumption of myeloid leukaemic leucocytes in vitro.
    Lancet (London, England), 1958, Dec-13, Volume: 2, Issue:7059

    Topics: Humans; In Vitro Techniques; Leukemia; Leukemia, Myeloid; Leukocytes; Metabolism; Oxygen Consumption

1958